Soluble Guanylate Cyclase Stimulator class drugs

1 result
Merck Sharp & Dohme LLC
Usage: VERQUVO® is indicated for reducing the risk of cardiovascular death and heart failure hospitalization in adults with symptomatic chronic heart failure and an ejection fraction less than 45%, particularly after hospitalization for heart failure or the need for outpatient IV diuretics.